Cosmica

Biotechnology

Overview

Cosmica Biosciences decodes the biology of aging. Built by the team behind the first inflammatory aging clock and the first epigenetic clock of intrinsic capacity — measure, track, and reroute aging with OrganAge™ and OptimAge™.

Funding and backers

Total raised
$200k
1 round on record
Latest round
$200k
Convertible Note · Jun 2023 · 3 yr ago
The money's age
Long since its last round
41 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3, 2023 Raised a round Convertible Note $200k · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Jun 2023 $200k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity COSMICA Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
David FurmanExecutive Officer, DirectorSEC Form D
Claire GuarryExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Lygg, Velorum Therapeutics
Antler
backs LEVIVE LABS PTE
Meta Planet
backs Velorum Therapeutics
SixThirty
backs Reframe Financial link
MyAsiaVC
backs Velorum Therapeutics
Alpha Edison
backs Reframe Financial link
Similar startupsby what they do, their industry and backers
One Genomics
Rewriting The Rules Of Aging. Frontier AI x Cellular Reprogramming For De-Aging.
Reframe Financial link
We are focused on helping today’s families prepare for the financial issues of aging - keeping you and your loved ones covered for life.
SportBoost AI11-50 employees
SportBoost AI is a technology startup that develops artificial intelligence solutions to help athletes measure, track, an improve their…
Lygg
Building New Anti-Aging Ingredients for Skincare.
Velorum Therapeutics11-50 employees
Creating transformational medicines by unlocking the biology of heme.
LEVIVE LABS PTE
Discover personalized longevity plans powered by DNA & epigenetics. Shop science-backed supplements that support healthy aging and cellular…

Financials

Total raised
$200k
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2023 $200k Details

People

David Furman
Executive Officer, Director
SEC Form D
Claire Guarry
Executive Officer
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco United States
HQ